Large-scale testing (Phase 3)Ended earlyNCT00161200
What this trial is testing
Esophageal Metaplasia Using a Novel Antibody: Reversibility by Proton Pump Inhibitor
Who this might be right for
Esophageal Metaplasia
University of Medicine and Dentistry of New Jersey 60